Alright, I've put in my order for a bunch of shares of ZEN on the news of the breast cancer prevention study. The stock closed Friday at 137 and change, shooting up 4 and some on news of merger with Glaxo Wellcome. This breakthrough in the NCI study will probably have ZEN opening around 140, I suspect. The company looks strong, with P/E at 35-ish. Anyone have any thoughts?
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates